# EDGAR Filing Document

**Accession Number:** 0000917520
**File Stem:** 0001193125-23-038716
**Filing Date:** 2023-2
**Character Count:** 14002
**Document Hash:** bf439588d8057a61b87c5279b60927c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-038716.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001193125-23-038716

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**GROUP MEMBERS**: PROVCO, LLC

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INTEGRA LIFESCIENCES HOLDINGS CORP
- **CENTRAL INDEX KEY:** 0000917520
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 510317849
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-45421
- **FILM NUMBER:** 23627226

**BUSINESS ADDRESS:**
- **STREET 1:** 1100 CAMPUS ROAD
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540
- **BUSINESS PHONE:** 6092750500

**MAIL ADDRESS:**
- **STREET 1:** 1100 CAMPUS ROAD
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTEGRA LIFESCIENCES CORP
- **DATE OF NAME CHANGE:** 19950614
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tru St Partnership, L.P.
- **CENTRAL INDEX KEY:** 0001824663
- **IRS NUMBER:** 232102776
- **STATE OF INCORPORATION:** PA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 795 EAST LANCASTER AVE., STE. 200
- **CITY:** VILLANOVA
- **STATE:** PA
- **ZIP:** 19085
- **BUSINESS PHONE:** (610) 520-2010

**MAIL ADDRESS:**
- **STREET 1:** 795 EAST LANCASTER AVE., STE. 200
- **CITY:** VILLANOVA
- **STATE:** PA
- **ZIP:** 19085

------

------

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**Schedule 13G** 

**Under the Securities Exchange Act of 1934** 

**(Amendment No. 20)\*** 

------

## Integra LifeSciences Holdings Corporation
**(Name of Issuer)** 

**Common stock, $.01 par value** 

**(Title of Class of Securities)** 

**457985208** 

**(CUSIP Number)** 

**December 31, 2022** 

**(Date of Event Which Requires Filing of this Statement)** 

------

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

------

---

| | | |
|:---|:---|:---|
| CUSIP No. 457985208 | SCHEDULE 13G | Page **2** of **9** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAMES OF REPORTING PERSON: Tru St Partnership LP<br> &nbsp;&nbsp;&nbsp;&nbsp;I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only): |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☒ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;0 shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;8,515,930 shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;0 shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;8,515,930 shares |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;8,515,930 shares |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;10.20% |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;PN |

---

------

---

| | | |
|:---|:---|:---|
| CUSIP No. 457985208 | SCHEDULE 13G | Page **3** of **9** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 1 | &nbsp;&nbsp;&nbsp;&nbsp;NAMES OF REPORTING PERSON: Provco, LLC<br> &nbsp;&nbsp;&nbsp;&nbsp;I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only): |
| &nbsp;&nbsp;&nbsp; 2 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br> &nbsp;&nbsp;&nbsp;&nbsp;(a) ☒ (b) ☐ |
| &nbsp;&nbsp;&nbsp; 3 | &nbsp;&nbsp;&nbsp;&nbsp;SEC USE ONLY |
| &nbsp;&nbsp;&nbsp; 4 | &nbsp;&nbsp;&nbsp;&nbsp;CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Delaware |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 5 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;0 shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 6 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;8,515,930 shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 7 | &nbsp;&nbsp;&nbsp;&nbsp;SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;0 shares |
| &nbsp;&nbsp;&nbsp; NUMBER OF<br> SHARES<br> BENEFICIALLY <br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH: | 8 | &nbsp;&nbsp;&nbsp;&nbsp;SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;8,515,930 shares |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 9 | &nbsp;&nbsp;&nbsp;&nbsp;AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;8,515,930 shares |
| &nbsp;&nbsp;&nbsp;10 | &nbsp;&nbsp;&nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| &nbsp;&nbsp;&nbsp;11 | &nbsp;&nbsp;&nbsp;&nbsp;PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>&nbsp;&nbsp;&nbsp;&nbsp;10.20% |
| &nbsp;&nbsp;&nbsp;12 | &nbsp;&nbsp;&nbsp;&nbsp;TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;OO |

---

------

---

| | | |
|:---|:---|:---|
| CUSIP No. 457985208 | SCHEDULE 13G | Page **4** of **9** |

---

---

| | |
|:---|:---|
| **ITEM 1.** **(a)** | **Name of Issuer:** Integra LifeSciences Holdings Corporation |
| **(b)** | **Address of Issuer's Principal Executive Offices:** 1100 Campus Road, Princeton, NJ 08540 |
| **ITEM 2.** **(a)** | **Name of Person Filing:** See (c) below |
| **(b)** | **Address or Principal Business Office:** See (c) below |
| **(c)** | **Citizenship of each Reporting Person is:**<br>Tru St Partnership LP<br> 795 East Lancaster Avenue, Suite 200<br> Villanova, Pennsylvania 19085<br> Pennsylvania limited partnership<br>AS of December 31, 2022, Provco Leasing Corporation was the corporate general partner of Tru St Partnership LP:<br>Provco Leasing Corporation<br> 1100 North Market Street, 4th Floor<br> Wilmington, Delaware 19890<br> Delaware corporation<br>As of January 1, 2023, Provco, LLC became the general partner of Tru St Partnership LP:<br>Provco, LLC<br> 1100 North Market Street, 4th Floor<br> Wilmington, Delaware 19890<br> Delaware limited liability company |
| **(d)** | **Title of Class of Securities:** common stock, $0.01 par value |
| **(e)** | **CUSIP Number:** 457985208 |
| **ITEM 3.** | Not applicable. |
| **ITEM 4.** | **Ownership**: Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. |
| **(a)** | **Amount beneficially owned**: As of December 31, 2022, Tru St Partnership LP ("Tru St") may be deemed the beneficial owner of 8,515,930 shares of common stock. Provco Leasing Corporation ("Provco Leasing") was the corporate general partner of Tru St as of December 31, 2022. Provco, LLC ("Provco") became the general partner of Tru St as of January 1, 2023. Provco Leasing was, as of December 31, 2022, the beneficial owner of 0 shares of common stock. |
| **(b)** | **Percent of Class**: Based on 83,518,163 shares of the Issuer's common stock outstanding as of October 24, 2022 as reported in the Issuer's Form 10-Q for the quarter ended September 30, 2022: Tru St may be deemed the beneficial owner of 10.20% of the Issuer's common stock; and Provco Leasing may be deemed the beneficial owner of 10.20% of the Issuer's common stock as of December 31, 2022. |

---

------

---

| | | |
|:---|:---|:---|
| CUSIP No. 457985208 | SCHEDULE 13G | Page **5** of **9** |

---

---

| | | |
|:---|:---|:---|
|  | **(c)** | The Reporting Persons have the power to vote or dispose of the number of shares as follows: |
|  |  | (i) **Sole power to vote or direct the vote**. Tru St may be deemed to have sole power to vote or direct the vote of 0 shares of common stock. Provco Leasing may be deemed to have sole power to vote or direct the vote of 0 shares of common stock. |
|  |  | (ii) **Shared power to vote or direct the vote**. As of December 31, 2022, Tru St and Provco Leasing may be deemed to share the power to vote or direct the vote with respect to 8,515,930 shares of common stock. |
|  |  | (iii) **Sole power to dispose or direct the disposition**. Tru St has sole power to dispose or control the disposition of 0 shares of common stock. Provco Leasing has sole power to dispose or control the disposition of 0 shares of common stock. |
|  |  | (iv) **Shared power to dispose or direct the disposition**. As of December 31, 2022, Tru St and Provco Leasing may be deemed to have shared power to dispose of or shared power to direct the disposition of 8,515,930 shares of common stock. |
| **ITEM 5.** | **Ownership of Five Percent or Less of a Class** | **Ownership of Five Percent or Less of a Class** |
|  | Not applicable. | Not applicable. |
| **ITEM 6.** | **Ownership of More than Five Percent on Behalf of Another Person** | **Ownership of More than Five Percent on Behalf of Another Person** |
|  | Not applicable. | Not applicable. |
| **ITEM 7.** | **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company** | **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company** |
|  | Not applicable. | Not applicable. |
| **ITEM 8.** | **Identification and Classification of Members of the Group** | **Identification and Classification of Members of the Group** |
|  | Exhibit A attached hereto identifies each member of the group filing this Schedule 13G/A pursuant to Rule 13d-1(d). | Exhibit A attached hereto identifies each member of the group filing this Schedule 13G/A pursuant to Rule 13d-1(d). |
| **ITEM 9.** | **Notice of Dissolution of Group** | **Notice of Dissolution of Group** |
|  | Not applicable. | Not applicable. |
| **ITEM 10.** | **Certification** | **Certification** |
|  | Not applicable. | Not applicable. |

---

------

---

| | | |
|:---|:---|:---|
| CUSIP No. 457985208 | SCHEDULE 13G | Page **6** of **9** |

---

**SIGNATURE** 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Date**: February 14, 2023

---

| | |
|:---|:---|
| TRU ST PARTNERSHIP LP | TRU ST PARTNERSHIP LP |
| By: | /s/ Gary Dilella |

---

---

| | |
|:---|:---|
| Name: | Gary DiLella |
| Its: | Vice President |
| PROVCO, LLC | PROVCO, LLC |
| By: | /s/ Gary Dilella |

---

Name: Gary DiLella <br> Its: Vice President

------

---

| | | |
|:---|:---|:---|
| CUSIP No. 457985208 | SCHEDULE 13G | Page **7** of **9** |

---

**Exhibit Index** 

---

| | | | |
|:---|:---|:---|:---|
| Exhibit | Title | Page No. | Page No. |
|  Exhibit A | Group Members |  | 8 |
|  Exhibit B | Joint Filing Agreement |  | 9 |

---

## Ex-99.A

Page **8** of **9**

EXHIBIT A

Group Members

Tru St Partnership LP

Provco, LLC

## Ex-99.B

Page **9** of **9**

EXHIBIT B

Joint Filing Agreement

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G/A (including amendments thereto) with respect to the common stock, par value $.01 per share of Integra LifeSciences Holdings Corporation, and further agree that this Joint Filing Agreement be included as Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 14th day of February, 2023.

---

| | |
|:---|:---|
| TRU ST PARTNERSHIP LP | TRU ST PARTNERSHIP LP |
| By: | /s/ Gary Dilella |

---

---

| | |
|:---|:---|
| Name: | Gary DiLella |
| Its: | Vice President |
| PROVCO, LLC | PROVCO, LLC |
| By: | /s/ Gary DiLella |

---

Name: Gary DiLella <br> Its: Vice President